Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Kalaris Therapeutics, Inc. | 2,409,928 | reported | 06 Jun 2024 | tx 32+2,579,273−3,758,335 |
| TAPIMMUNE INC | 250,000 | reported | 31 Oct 2025 | tx 12+2,098,738−33,465 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 31 Oct 2025 | GRANT_AWARD | TAPIMMUNE INC | 250,000 | 0.00 USD | deriv |
| 12 Feb 2025 | GRANT_AWARD | TAPIMMUNE INC | 50,000 | 0.00 USD | deriv |
| 06 Jun 2024 | GRANT_AWARD | Kalaris Therapeutics, Inc. | 35,000 | 0.00 USD | |
| 11 May 2023 | GRANT_AWARD | Kalaris Therapeutics, Inc. | 35,000 | 0.00 USD | |
| 10 May 2023 | GRANT_AWARD | TAPIMMUNE INC | 100,000 | 0.00 USD | deriv |
| 27 Feb 2023 | GRANT_AWARD | TAPIMMUNE INC | 46,487 | 0.00 USD | deriv |
| 17 May 2022 | GRANT_AWARD | Kalaris Therapeutics, Inc. | 27,500 | 0.00 USD | deriv |
| 24 Mar 2022 | GRANT_AWARD | TAPIMMUNE INC | 140,823 | 0.00 USD | |
| 24 Mar 2022 | TAX_WITHHOLDING | TAPIMMUNE INC | 33,465 | 0.48 USD | |
| 17 Feb 2022 | GRANT_AWARD | TAPIMMUNE INC | 160,000 | 0.00 USD | deriv |
| 25 May 2021 | GRANT_AWARD | Kalaris Therapeutics, Inc. | 22,500 | 0.00 USD | deriv |
| 16 Mar 2021 | PURCHASE | TAPIMMUNE INC | 571,428 | 1.75 USD | |
| 03 Mar 2021 | SALE | Kalaris Therapeutics, Inc. | 7,546 | 38.63 USD | |
| 03 Mar 2021 | SALE | Kalaris Therapeutics, Inc. | 7,142 | 38.22 USD | |
| 03 Mar 2021 | SALE | Kalaris Therapeutics, Inc. | 1,300 | 37.01 USD | |
| 02 Mar 2021 | SALE | Kalaris Therapeutics, Inc. | 1,803 | 39.10 USD | |
| 01 Mar 2021 | SALE | Kalaris Therapeutics, Inc. | 11,570 | 38.28 USD | |
| 02 Mar 2021 | SALE | Kalaris Therapeutics, Inc. | 9,001 | 38.30 USD | |
| 02 Mar 2021 | SALE | Kalaris Therapeutics, Inc. | 4,190 | 37.28 USD | |
| 01 Mar 2021 | SALE | Kalaris Therapeutics, Inc. | 700 | 39.53 USD | |
| 01 Mar 2021 | SALE | Kalaris Therapeutics, Inc. | 20,584 | 38.73 USD | |
| 23 Feb 2021 | SALE | Kalaris Therapeutics, Inc. | 2,300 | 40.13 USD | |
| 23 Feb 2021 | SALE | Kalaris Therapeutics, Inc. | 600 | 40.97 USD | |
| 23 Feb 2021 | SALE | Kalaris Therapeutics, Inc. | 4,825 | 39.11 USD | |
| 22 Feb 2021 | SALE | Kalaris Therapeutics, Inc. | 380 | 43.40 USD |